Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB) (SYMPROVE III)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: April 8, 2009
Last updated: June 20, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)